How many patents does
Halozyme have?
patents
643
families
38
granted
144
applications
499
US
121
EP
62
JP
53
WO
46
KR
43
CN
31
RoW
287
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Halozyme
Top ten assignees appearing on patents
2009 - 2018
| halozyme | 472 |
| baxter healthcare | 18 |
| baxter | 16 |
| baxalta | 14 |
| halozyme therapeutics | 3 |
| thompson, curtis | 1 |
| delfmems | 1 |
| deliatroph pharmaceuticals | 1 |
| hyalozyme therapeutics | 1 |
2009
| halozyme | 26 |
| baxter healthcare | 4 |
| baxter | 4 |
| delfmems | 1 |
2018
| halozyme | 34 |
| baxter healthcare | 1 |
| baxter | 1 |
Halozyme
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and p… 🛈 | 87 | 2003 |
| super fast-acting insulin compositions | 49 | 2008 |
| combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane | 38 | 2012 |
| extended soluble ph20 polypeptides and uses thereof | 37 | 2008 |
| soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglyc… 🛈 | 31 | 2003 |
| ph20 polypeptide variants, formulations and uses thereof | 31 | 2011 |
| combinations and methods for subcutaneous administration of immune globulin and hyaluron… 🛈 | 29 | 2008 |
| in vivo temporal control of activatable matrix-degrading enzymes | 28 | 2008 |
| companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | 27 | 2011 |
| stable formulations of a hyaluronan-degrading enzyme | 27 | 2011 |